| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | IJ2XP0ID0K |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C9H11FN6O4 |
| Molecular Weight | 286.22 |
| AlogP | -0.95 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 159.36 |
| Molecular species | None |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 20.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Human immunodeficiency virus type 1 reverse transcriptase inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4650447 |
| FDA SRS | IJ2XP0ID0K |
CONTENTS